Timothy J Siglock, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3680 Hill Blvd, Caremount Medical Pc, Jefferson Valley, NY 10535 Phone: 914-241-1050 Fax: 914-245-7836 |
Robert R Parks, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3680 Hill Blvd, Care Mount Medical, Pc, Jefferson Valley, NY 10535 Phone: 914-245-7700 Fax: 914-245-7836 |
News Archive
Merck Frosst Canada Ltd. announced today that its new diabetes treatment, JANUMET(TM) (sitagliptin/metformin HCI, MSD), has received Notice of Compliance (NoC) in Canada.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
Of dozens of candidates potentially involved in increasing a person's risk for the most common type of Alzheimer's disease that affects more than 5 million Americans over the age of 65, one gene that keeps grabbing Johns Hopkins researchers' attention makes a protein called neuroglobin.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
Guided Therapeutics, Inc. today announced that it was awarded $1.0 million to fund the second year of a $2.5 million grant from the National Cancer Institute (NCI) announced in 2009.
› Verified 1 days ago